Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation

Yuriko Minegishi1, Yoshio Shibagaki, Anna Mizutani

  • 1Division of Systems Biomedical Technology, The University of Tokyo, Tokyo, Japan.

Cancer Science
|January 3, 2013
PubMed

Insights

Researchers discovered a new pathway involving FRS2β, CIN85, CD2AP, and Cbl that downregulates ErbB2 (HER2) protein. This finding offers potential new targets for treating ErbB2-overexpressing cancers.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • ErbB2 (HER2) receptor tyrosine kinase overexpression drives tumorigenesis.
  • Mechanisms controlling ErbB2 protein levels are not fully understood.

Purpose of the Study:

  • To identify novel mechanisms regulating ErbB2 protein levels.
  • To elucidate the role of adaptor protein FRS2β in ErbB2 downregulation.

Main Methods:

  • Investigated protein-protein interactions using co-immunoprecipitation.
  • Assessed protein levels via Western blotting.
  • Utilized knockdown experiments and pharmacological inhibitors.
  • Performed immunohistochemical analysis on human breast cancer tissues.

Main Results:

  • Identified a novel FRS2β-CIN85/CD2AP-Cbl complex involved in ErbB2 downregulation.
  • FRS2β mediates lysosomal trafficking and degradation of ErbB2.
  • Knockdown of FRS2β components or Cbl impaired ErbB2 downregulation.
  • Low FRS2β expression correlated with high ErbB2 levels in breast cancer.

Conclusions:

  • An FRS2β-CIN85/CD2AP-Cbl axis regulates ErbB2 protein levels.
  • This axis represents a potential therapeutic target for ErbB2-overexpressing tumors.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...